From the Journals

Understanding Protocol AO, the DRCR Retina Network’s Study of Home OCT

A conversation with Christina Y. Weng, MD, MBA

Share

  • 1

    Home OCT may allow personalized care and better outcomes for neovascular age-related macular degeneration patients.

  • 2

    Benefits of home OCT include earlier disease detection and minimization of undertreatment.

  • 3

    Protocol AO measures change in visual acuity through electronic-ETDRS visual acuity testing.

  • 4

    Patient adherence is essential for the successful implementation of home OCT–guided treatment.

  • 5

    Home OCT has potential financial implications and will require workflow integration in clinical practice.

Original Source(s)

Understanding Protocol AO, the DRCR Retina Network’s Study of Home OCT

A conversation with Christina Y. Weng, MD, MBA

  • by Christina Y. Weng, MD, MBA, Jim Gallagher, senior managing editor

  • January 1, 2025

  • 11 min

Related Content

PRISM Trial Update Presented at RWC

Mark Barakat, MD, provided an update on the PRISM clinical trial for 4D-150 (4DMT) for wet AMD at the Retina World Congress meeting in Fort Lauderdale.

Real-World nAMD Treatment Patterns Reveal Cost of Switching

Analysis of Medicare claims show increases in drug-related expenditures after initial low-cost therapy.

Migaldendranib May Move the Needle in AMD, DME

Michael A. Singer, MD, shares early phase 2 data supporting D-4517.2 as a safe and effective subcutaneous therapy, reducing injection burden and preserving vision.